venBio Global Strategic GP II, L.P., 10% Owner at Akero Therapeutics, Inc. (AKRO), sold 20,046 shares at $27.05 ($543K) on 2020-02-11, disclosed to the SEC on 2020-02-12.
Open-market sale of $543k AKRO by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $27.08 | 7,836 | $212K | 39.1% |
| 2 | $27.08 | 7,836 | $212K | 39.1% |
| 3 | $27.05 | 2,184 | $59K | 10.9% |
| 4 | $27.05 | 2,184 | $59K | 10.9% |
| 5 | $27.14 | 6 | $163 | 0.0% |
| Total | $27.07 avg | 20,046 |
| $543K |
| 100% |
| Filing → |